Clinical Trials Directory

Trials / Completed

CompletedNCT02374684

Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects

A Within-group Randomized, Double-Blind, Placebo-Controlled, Single/ Multiple Dose Study to Assess the Safety , Tolerability, Pharmacokinetics and Food Effect of Methosulide After Oral Administration In Healthy Adult Subjects.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Hubei Biological Medicine Industrial Technology Institute Co., Ltd. · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the safety and tolerability, and to evaluate the pharmacokinetic characteristics and food effect of Methosulide after oral administration in healthy adult subjects.

Detailed description

1. Dose-escalation study of single oral administration of Methosulide in healthy adults to assess the safety and tolerability. 2. Multiple-dose study of Methosulide in healthy adults to assess the safety and tolerability. 3. Dose-escalation study of single oral administration of Methosulide in healthy adults to evaluate the pharmacokinetic characteristics 4. Multiple-dose study of Methosulide in healthy adults to evaluate the pharmacokinetics characteristics 5. Single dose,and cross-over study of Methosulide in healthy adults to evaluate the pharmacokinetic characteristics and effect of food.

Conditions

Interventions

TypeNameDescription
DRUGMethosulideTolerability Study: Period I:Single oral administration,dose-escalation of Methosulide(six dose groups:25mg-250mg) Period II:Repeated oral administration of Methosulide(group 1:MTD(maximum tolerated dose)/250mg ,group 2:depending on the adverse drug reaction,150mg/250mg) Pharmacokinetic Study: Period I:Single oral administration,dose-escalation of Methosulide(three dose groups:50mg,100mg,200mg/250mg) Period II:Repeated oral administration of Methosulide(group 1:MTD(maximum tolerated dose)/250mg ,group 2:depending on the adverse drug reaction,150mg/250mg) Food Effect on the Pharmacokinetics: single dose(100mg),two status(Feeding and fasting), washout period(7 days)
DRUGPlaceboPlacebo to match with experimental groups

Timeline

Start date
2015-02-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2015-03-02
Last updated
2016-02-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02374684. Inclusion in this directory is not an endorsement.

Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects (NCT02374684) · Clinical Trials Directory